SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000912057-15-000234
Filing Date
2015-08-03
Accepted
2015-08-03 16:46:49
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 a2225533zs-3.htm S-3 265445
2 EX-4.3 a2225533zex-4_3.htm EX-4.3 51465
3 EX-4.4 a2225533zex-4_4.htm EX-4.4 389531
4 EX-5.1 a2225533zex-5_1.htm EX-5.1 38306
5 EX-23.1 a2225533zex-23_1.htm EX-23.1 2382
6 G164622KSI001.GIF g164622ksi001.gif GRAPHIC 31372
  Complete submission text file 0000912057-15-000234.txt   791432
Mailing Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901
Business Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-206052 | Film No.: 151022885
SIC: 2834 Pharmaceutical Preparations